CAXII Is a sero-diagnostic marker for lung cancer.
To develop sero-diagnostic markers for lung cancer, we generated monoclonal antibodies using pulmonary adenocarcinoma (AD)-derived A549 cells as antigens by employing the random immunization method. Hybridoma supernatants were immunohistochemically screened for antibodies with AMeX-fixed and paraffi...
Saved in:
Main Authors: | Makoto Kobayashi, Toshihide Matsumoto, Shinichiro Ryuge, Kengo Yanagita, Ryo Nagashio, Yoshitaka Kawakami, Naoki Goshima, Shi-Xu Jiang, Makoto Saegusa, Akira Iyoda, Yukitoshi Satoh, Noriyuki Masuda, Yuichi Sato |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/f42a5fdb1ecd4432afc4c81d59c4e9e3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
by: Rui Han, et al.
Published: (2021) -
Derrame pleural sero-fibrinoso en un lactante tuberculoso negativo
by: OYARCE ROJAS,PEDRO, et al.
Published: (1949) -
Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
by: Emily J. Strong, et al.
Published: (2018) -
Integrated human-animal sero-surveillance of Brucellosis in the pastoral Afar and Somali regions of Ethiopia.
by: Rea Tschopp, et al.
Published: (2021) -
Stabilizing Genetically Unstable Simple Sequence Repeats in the <named-content content-type="genus-species">Campylobacter jejuni</named-content> Genome by Multiplex Genome Editing: a Reliable Approach for Delineating Multiple Phase-Variable Genes
by: Shouji Yamamoto, et al.
Published: (2021)